These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8341715)

  • 1. Diazepam dependence prevented by glutamate antagonists.
    Steppuhn KG; Turski L
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6889-93. PubMed ID: 8341715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
    Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
    Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
    Donevan SD; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
    Chapman AG; Smith SE; Meldrum BS
    Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.
    Bernert H; Turski L
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
    Chapman AG; al-Zubaidy Z; Meldrum BS
    Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.
    Steppuhn KG; Turski L
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1063-70. PubMed ID: 8509995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.
    Block F; Schwarz M
    Eur J Pharmacol; 1994 Apr; 256(2):149-53. PubMed ID: 8050465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice.
    Pouw B; Nour M; Matsumoto RR
    Eur J Pharmacol; 1999 Dec; 386(2-3):181-6. PubMed ID: 10618468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats.
    Stauch Slusher B; Rissolo KC; Anzilotti KF; Jackson PF
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):145-9. PubMed ID: 8526999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats.
    Tsuda M; Suzuki T; Misawa M
    Brain Res; 1998 Apr; 790(1-2):82-90. PubMed ID: 9593834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.
    Kapus GL; Gacsályi I; Vegh M; Kompagne H; Hegedus E; Leveleki C; Hársing LG; Barkóczy J; Bilkei-Gorzó A; Lévay G
    Psychopharmacology (Berl); 2008 Jun; 198(2):231-41. PubMed ID: 18363046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of desensitization and subunit expression for kainate receptor-mediated neurotoxicity in murine neocortical cultures.
    Jensen JB; Schousboe A; Pickering DS
    J Neurosci Res; 1999 Jan; 55(2):208-17. PubMed ID: 9972823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.
    Izzo E; Auta J; Impagnatiello F; Pesold C; Guidotti A; Costa E
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3483-8. PubMed ID: 11248104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat.
    Kovács AD; Egyed A
    Neurobiology (Bp); 1996; 4(1-2):59-72. PubMed ID: 9116695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.